KAM
SRGA

Krensavage Asset Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Krensavage Asset Management’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-211,098
Closed -$6.9M – 13
2021
Q3 		$6.9M Sell
211,098
-2,338
-1% -$85.6K 2.17% 9
2021
Q2 		$8.9M Sell
213,436
-1,544
-0.7% -$79.1K 3.02% 8
2021
Q1 		$14.1M Buy
214,980
+866
+0.4% +$60.4K 4.87% 8
2020
Q4 		$14.1M Buy
214,114
+5,740
+3% +$374K 4.11% 9
2020
Q3 		$11.3M Buy
208,374
+13,322
+7% +$1.02M 3.6% 9
2020
Q2 		$18.6M Buy
195,052
+60,793
+45% +$4.53M 5.06% 9
2020
Q1 		$6.89M Buy
134,259
+13,294
+11% +$1.39M 2.22% 10
2019
Q4 		$9.94M Sell
120,965
-8,712
-7% -$611K 3.39% 9
2019
Q3 		$11.1M Sell
129,677
-914
-0.7% -$97.6K 4.26% 8
2019
Q2 		$16.6M Sell
130,591
-1,809
-1% -$261K 5.4% 8
2019
Q1 		$23.9M Sell
132,400
-15,726
-11% -$2.28M 6.45% 9
2018
Q4 		$16.4M Sell
148,126
-622
-0.4% -$81K 5.55% 8
2018
Q3 		$20.1M Sell
148,748
-102
-0.1% -$14.1K 5.16% 8
2018
Q2 		$20.5M Buy
148,850
+3,457
+2% +$476K 5.25% 8
2018
Q1 		$20.1M Buy
145,393
+898
+0.6% +$122K 4.87% 7
2017
Q4 		$17.8M Sell
144,495
-2,632
-2% -$361K 5.54% 9
2017
Q3 		$20.1M Sell
147,127
-1,709
-1% -$258K 6.26% 9
2017
Q2 		$26.1M Buy
148,836
+871
+0.6% +$124K 7.93% 7
2017
Q1 		$17.8M Buy
147,965
+7,400
+5% +$770K 5.73% 9
2016
Q4 		$13.7M Buy
140,565
+1,195
+0.9% +$110K 4.91% 12
2016
Q3 		$13.1M Buy
139,370
+17,770
+15% +$1.78M 4.73% 11
2016
Q2 		$13.1M Buy
121,600
+6,697
+6% +$784K 4.72% 12
2016
Q1 		$13.8M Buy
114,903
+12,339
+12% +$1.3M 4.95% 9
2015
Q4 		$12.2M Buy
102,564
+41,608
+68% +$5.37M 3.9% 12
2015
Q3 		$10.4M Buy
60,956
+1,954
+3% +$374K 3.76% 14
2015
Q2 		$11.4M Buy
59,002
+2,287
+4% +$425K 4.31% 11
2015
Q1 		$8.4M Buy
56,715
+1,666
+3% +$254K 3.83% 13
2014
Q4 		$8.59M Buy
+55,049
New +$7.93M 4.79% 11

Other funds holding SRGA

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Krensavage Asset Management's SRGA Position: Q4 2021 in Review

Krensavage Asset Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q4 2021, closing a stake of 211,098 shares — an estimated $6.9M sold.

Krensavage Asset Management first reported a position in SRGA in Q4 2014 and held it in 28 quarters. The position peaked at $26.1M in Q2 2017. 72 funds tracked by Wall St. Rank hold SRGA as of Q4 2021.

  • Krensavage Asset Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Krensavage Asset Management sold 211,098 Surgalign Holdings, Inc. Common Stock shares in Q4 2021, an estimated $6.9M.
  • Krensavage Asset Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q4 2014 and held it in 28 quarters.
  • Krensavage Asset Management's Surgalign Holdings, Inc. Common Stock position peaked at $26.1M in Q2 2017.
  • 72 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q4 2021.

Based on Krensavage Asset Management's 13F filing for Q4 2021, filed 15 Feb 2022.